Research Article

Clinical Features of Acute Anterior Uveitis with Complicated Course in a Slovenian Patient Population

Table 2

Clinical features, ocular complications, investigations performed in patients and treatment choices.

VariableHLA+HLA−Odds ratioConfidence interval value
PercentageNumber (out of 27)PercentageNumber (out of 10)With Haldane–Anscombe correctionUpper boundLower boundUsing Fisher's exact test

Clinical featuresFibrin exudation63%170%035.01.9661.00.001
Hypopyon23%6 (out of 26)0%06.70.3129.90.157
Posterior synechiae74%2050%52.70.611.60.240

Ocular complicationsCataract formation30%840%40.60.22.70.696
Cystoid macular edema8%2 (out of 26)20%20.40.12.40.353
Ocular hypertension15%440%40.30.11.30.174
Secondary glaucoma4%110%10.40.03.90.473

Investigations performed in patientsMacular OCT67%1860%61.40.35.70.716
Aqueous humor tap30%830%30.90.24.21.000
Sacroiliac joint X-ray22%630%30.70.13.00.679
Serology (Treponema, Borrelia)26%730%30.80.23.61.000
QuantiFERON-TB22%620%21.00.25.41.000
Aerum angiotensin converting enzyme4%10%01.20.031.61.000
Other ocular imaging (FA, ICG, and US)11%340%40.20.01.10.069

Treatment choicesTopical corticosteroids1271102.60.1140.71.000
Topical mydriatics1271102.60.1140.71.000
Periocular corticosteroids11%310%10.90.17.11.000
Systemic corticosteroids4%110%10.40.03.90.473
Methotrexate26%710%12.30.315.20.404
NSAID4%10%01.20.031.61.000
Biologics11%30%03.00.163.40.548